The Effect of Diabetes Mellitus on the Recurrence of Atrial Fibrillation after Ablation
Diabetes mellitus (DM) plays a crucial role in the regulation of atrial fibrillation (AF). This study aimed to evaluate the outcome of pulmonary vein isolation (PVI) using a single-shot device in patients with AF and DM. A total of 531 consecutive patients undergoing initial cryoballoon (CB)-guided...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-10-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/10/21/4863 |
| _version_ | 1797512286818009088 |
|---|---|
| author | Denise Guckel Khuraman Isgandarova Leonard Bergau Misagh Piran Mustapha El Hamriti Guram Imnadze Martin Braun Moneeb Khalaph Thomas Fink Vanessa Sciacca Georg Nölker Young-Hee Lee-Barkey Diethelm Tschöpe Philipp Sommer Christian Sohns |
| author_facet | Denise Guckel Khuraman Isgandarova Leonard Bergau Misagh Piran Mustapha El Hamriti Guram Imnadze Martin Braun Moneeb Khalaph Thomas Fink Vanessa Sciacca Georg Nölker Young-Hee Lee-Barkey Diethelm Tschöpe Philipp Sommer Christian Sohns |
| author_sort | Denise Guckel |
| collection | DOAJ |
| description | Diabetes mellitus (DM) plays a crucial role in the regulation of atrial fibrillation (AF). This study aimed to evaluate the outcome of pulmonary vein isolation (PVI) using a single-shot device in patients with AF and DM. A total of 531 consecutive patients undergoing initial cryoballoon (CB)-guided PVI were evaluated. Two hundred eighty-one patients (53%) suffered from paroxysmal AF (PAF; mean age 51 ± 23.2 years, 26% female), 250 patients (48%) from persistent AF (PERS; 64 ± 10.0 years old, 30% female) and 80 patients (15%) were diagnosed with coincidental DM (68 ± 19.6 years old, 30% female). Follow-up visits were performed at 3, 6 and 12 months including 7-day Holter ECGs. Primary endpoint was the first documented recurrence of atrial tachyarrhythmia. AF recurrence occurred in 26% (140 patients). PAF patients with DM presented with a significantly higher risk for arrhythmia recurrence (Kaplan Meier analysis; Log rank <i>p</i> < 0.001 *). Multivariate analyses found DM to be an independent predictor (IP) for AF recurrence (<i>p</i> = 0.009 *, hazard ratio (HR) 4.363, confidence interval (CI) 1.456–13.074). In PERS, DM was associated with a 43% increase in AF recurrence (<i>p</i> = 0.320, HR 1.427, CI 0.707–2.879). DM has relevant effects on AF recurrence after PVI-only ablation approaches for AF. Major differences were observed in PAF as DM seems to favor the development of individual arrhythmia substrate, which is usually not yet present in PAF. In PERS, DM effects are less pronounced as individual fibrosis has already developed. Thus, personalized paths addressing individual arrhythmia substrates are needed in this specific cohort of patients. |
| first_indexed | 2024-03-10T05:59:45Z |
| format | Article |
| id | doaj.art-69be5d7a167940629a1ff3782342ece0 |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-10T05:59:45Z |
| publishDate | 2021-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-69be5d7a167940629a1ff3782342ece02023-11-22T21:03:46ZengMDPI AGJournal of Clinical Medicine2077-03832021-10-011021486310.3390/jcm10214863The Effect of Diabetes Mellitus on the Recurrence of Atrial Fibrillation after AblationDenise Guckel0Khuraman Isgandarova1Leonard Bergau2Misagh Piran3Mustapha El Hamriti4Guram Imnadze5Martin Braun6Moneeb Khalaph7Thomas Fink8Vanessa Sciacca9Georg Nölker10Young-Hee Lee-Barkey11Diethelm Tschöpe12Philipp Sommer13Christian Sohns14Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyInstitute for Radiology, Nuclear Medicine and Molecular Imaging, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyDiabetes Center, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyDiabetes Center, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyClinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, 32545 Bad Oeynhausen, GermanyDiabetes mellitus (DM) plays a crucial role in the regulation of atrial fibrillation (AF). This study aimed to evaluate the outcome of pulmonary vein isolation (PVI) using a single-shot device in patients with AF and DM. A total of 531 consecutive patients undergoing initial cryoballoon (CB)-guided PVI were evaluated. Two hundred eighty-one patients (53%) suffered from paroxysmal AF (PAF; mean age 51 ± 23.2 years, 26% female), 250 patients (48%) from persistent AF (PERS; 64 ± 10.0 years old, 30% female) and 80 patients (15%) were diagnosed with coincidental DM (68 ± 19.6 years old, 30% female). Follow-up visits were performed at 3, 6 and 12 months including 7-day Holter ECGs. Primary endpoint was the first documented recurrence of atrial tachyarrhythmia. AF recurrence occurred in 26% (140 patients). PAF patients with DM presented with a significantly higher risk for arrhythmia recurrence (Kaplan Meier analysis; Log rank <i>p</i> < 0.001 *). Multivariate analyses found DM to be an independent predictor (IP) for AF recurrence (<i>p</i> = 0.009 *, hazard ratio (HR) 4.363, confidence interval (CI) 1.456–13.074). In PERS, DM was associated with a 43% increase in AF recurrence (<i>p</i> = 0.320, HR 1.427, CI 0.707–2.879). DM has relevant effects on AF recurrence after PVI-only ablation approaches for AF. Major differences were observed in PAF as DM seems to favor the development of individual arrhythmia substrate, which is usually not yet present in PAF. In PERS, DM effects are less pronounced as individual fibrosis has already developed. Thus, personalized paths addressing individual arrhythmia substrates are needed in this specific cohort of patients.https://www.mdpi.com/2077-0383/10/21/4863diabetes mellitusatrial fibrillationablationpulmonary vein isolationcryoballoonfibrosis |
| spellingShingle | Denise Guckel Khuraman Isgandarova Leonard Bergau Misagh Piran Mustapha El Hamriti Guram Imnadze Martin Braun Moneeb Khalaph Thomas Fink Vanessa Sciacca Georg Nölker Young-Hee Lee-Barkey Diethelm Tschöpe Philipp Sommer Christian Sohns The Effect of Diabetes Mellitus on the Recurrence of Atrial Fibrillation after Ablation Journal of Clinical Medicine diabetes mellitus atrial fibrillation ablation pulmonary vein isolation cryoballoon fibrosis |
| title | The Effect of Diabetes Mellitus on the Recurrence of Atrial Fibrillation after Ablation |
| title_full | The Effect of Diabetes Mellitus on the Recurrence of Atrial Fibrillation after Ablation |
| title_fullStr | The Effect of Diabetes Mellitus on the Recurrence of Atrial Fibrillation after Ablation |
| title_full_unstemmed | The Effect of Diabetes Mellitus on the Recurrence of Atrial Fibrillation after Ablation |
| title_short | The Effect of Diabetes Mellitus on the Recurrence of Atrial Fibrillation after Ablation |
| title_sort | effect of diabetes mellitus on the recurrence of atrial fibrillation after ablation |
| topic | diabetes mellitus atrial fibrillation ablation pulmonary vein isolation cryoballoon fibrosis |
| url | https://www.mdpi.com/2077-0383/10/21/4863 |
| work_keys_str_mv | AT deniseguckel theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT khuramanisgandarova theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT leonardbergau theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT misaghpiran theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT mustaphaelhamriti theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT guramimnadze theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT martinbraun theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT moneebkhalaph theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT thomasfink theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT vanessasciacca theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT georgnolker theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT youngheeleebarkey theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT diethelmtschope theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT philippsommer theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT christiansohns theeffectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT deniseguckel effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT khuramanisgandarova effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT leonardbergau effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT misaghpiran effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT mustaphaelhamriti effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT guramimnadze effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT martinbraun effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT moneebkhalaph effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT thomasfink effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT vanessasciacca effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT georgnolker effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT youngheeleebarkey effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT diethelmtschope effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT philippsommer effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation AT christiansohns effectofdiabetesmellitusontherecurrenceofatrialfibrillationafterablation |